carefully in patients suffering with depression because of the possibility of worsening symptoms. Rozerem should also not be used if you are taking Fluvoxamine due to adverse reactions.

Rozerem is just one of the many insomnia medications available on the market today. It is important that you discuss with your health care provider if prescription medications are right to treat your insomnia.

Rozerem has demonstrated in research studies to be non-addictive and has not been labeled by the FDA as a controlled substan

The most common sleep complaint in the United States today impacts many of the population at some time in their lives.

This sleep disorder is known as insomnia. Insomnia keeps you from feeling refreshed even after a full night of sleep.

When suffering from insomnia you may experience difficulty with falling asleep or staying asleep, waking up too early or a general overall poor quality of sleep. It is rather common for those suffering from insomnia to frequently feel irritated, tired, frustrated and overall grumpy.

In 2006 the Food and Drug Administration approved Rozerem (ramelteon) at the 8 mg dosage for use in the treatment of both acute and chronic insomnia.

Rozerem is the very first insomnia treatment medication on the market that acts as a melatonin receptor agonist.

Melatonin is thought to be involved in the maintenance the circadian rhythm which is the foundation of the normal sleep and wake cycle. Rozerem targets two receptors, the MT1 or the MT2, in the suprachiasmatic nucleus, which controls the circadian rhythm. One of the best qualities of this insomnia medication is that it was not identified by the FDA as a controlled substance.

This is an important differentiation between Rozerem and other sleep medications on the market.

Another important hallmark of Rozerem is that clinical trials have indicated no evidence that patients become dependent on or abusive of the drug.

Rozerem also does not have a limitation for the duration of its use. Again, this is an important distinction since many insomnia drugs are indicated for use during a seven to ten day period only because of the potential for drug dependency.

Rozerem should be taken 30 minutes before bedtime and in most people is very well tolerated. Most common side effects associated with this insomnia medication were reported to be dizziness, fatigue, and somnolence.

A couple of important things to remember with the use of this drug are that it should not be used if you have a serious liver condition because it is metabolized by the liver.

It should also be used carefully in patients suffering with depression because of the possibility of worsening symptoms. Rozerem should also not be used if you are taking Fluvoxamine due to adverse reactions.

Rozerem is just one of the many insomnia medications available on the market today. It is important that you discuss with your health care provider if prescription medications are right to treat your insomnia.

Rozerem has demonstrated in research studies to be non-addictive and has not been labeled by the FDA as a controlled substan

.

In 2006 the Food and Drug Administration approved Rozerem (ramelteon) at the 8 mg dosage for use in the treatment of both acute and chronic insomnia.

Rozerem is the very first insomnia treatment medication on the market that acts as a melatonin receptor agonist.

Melatonin is thought to be involved in the maintenance the circadian rhythm which is the foundation of the normal sleep and wake cycle. Rozerem targets two receptors, the MT1 or the MT2, in the suprachiasmatic nucleus, which controls the circadian rhythm. One of the best qualities of this insomnia medication is that it was not identified by the FDA as a controlled substance.

This is an important differentiation between Rozerem and other sleep medications on the market.

Another important hallmark of Rozerem is that clinical trials have indicated no evidence that patients become dependent on or abusive of the drug.

Rozerem also does not have a limitation for the duration of its use. Again, this is an important distinction since many insomnia drugs are indicated for use during a seven to ten day period only because of the potential for drug dependency.

Rozerem should be taken 30 minutes before bedtime and in most people is very well tolerated. Most common side effects associated with this insomnia medication were reported to be dizziness, fatigue, and somnolence.

A couple of important things to remember with the use of this drug are that it should not be used if you have a serious liver condition because it is metabolized by the liver.

It should also be used carefully in patients suffering with depression because of the possibility of worsening symptoms. Rozerem should also not be used if you are taking Fluvoxamine due to adverse reactions.

Rozerem is just one of the many insomnia medications available on the market today. It is important that you discuss with your health care provider if prescription medications are right to treat your insomnia.

Rozerem has demonstrated in research studies to be non-addictive and has not been labeled by the FDA as a controlled substan

hythm. One of the best qualities of this insomnia medication is that it was not identified by the FDA as a controlled substance.

This is an important differentiation between Rozerem and other sleep medications on the market.

Another important hallmark of Rozerem is that clinical trials have indicated no evidence that patients become dependent on or abusive of the drug.

Rozerem also does not have a limitation for the duration of its use. Again, this is an important distinction since many insomnia drugs are indicated for use during a seven to ten day period only because of the potential for drug dependency.

Rozerem should be taken 30 minutes before bedtime and in most people is very well tolerated. Most common side effects associated with this insomnia medication were reported to be dizziness, fatigue, and somnolence.

A couple of important things to remember with the use of this drug are that it should not be used if you have a serious liver condition because it is metabolized by the liver.

It should also be used carefully in patients suffering with depression because of the possibility of worsening symptoms. Rozerem should also not be used if you are taking Fluvoxamine due to adverse reactions.

Rozerem is just one of the many insomnia medications available on the market today. It is important that you discuss with your health care provider if prescription medications are right to treat your insomnia.

Rozerem has demonstrated in research studies to be non-addictive and has not been labeled by the FDA as a controlled substan

dicated for use during a seven to ten day period only because of the potential for drug dependency.

Rozerem should be taken 30 minutes before bedtime and in most people is very well tolerated. Most common side effects associated with this insomnia medication were reported to be dizziness, fatigue, and somnolence.

A couple of important things to remember with the use of this drug are that it should not be used if you have a serious liver condition because it is metabolized by the liver.

It should also be used carefully in patients suffering with depression because of the possibility of worsening symptoms. Rozerem should also not be used if you are taking Fluvoxamine due to adverse reactions.

Rozerem is just one of the many insomnia medications available on the market today. It is important that you discuss with your health care provider if prescription medications are right to treat your insomnia.

Rozerem has demonstrated in research studies to be non-addictive and has not been labeled by the FDA as a controlled substan

carefully in patients suffering with depression because of the possibility of worsening symptoms. Rozerem should also not be used if you are taking Fluvoxamine due to adverse reactions.

Rozerem is just one of the many insomnia medications available on the market today. It is important that you discuss with your health care provider if prescription medications are right to treat your insomnia.

Rozerem has demonstrated in research studies to be non-addictive and has not been labeled by the FDA as a controlled substance.

Both of these findings seem to be contributing to the popularity of Rozerem as a new insomnia treatment.